12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. 180 Life Sciences (ATNF) saw a 38.2% increase, while GlucoTrack (GCTK) dropped by 15.5%. Other notable gainers include Redhill Biopharma (RDHL), Trinity Biotech (TRIB), Blue Water Biotech (BWV), CohBar (CWBR), and DermTech (DMTK). On the losing side, Better Therapeutics (BTTX), Verve Therapeutics (VERV), Envoy Medical (COCH), Sonnet BioTherapeutics (SONN), and Personalis (PSNL) saw declines in their stock prices.
November 28, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Better Therapeutics shares fell by 9.43% to $0.19, with a market cap of $8.8 million.
The decline in BTTX's stock price could suggest a negative short-term outlook, potentially due to investor sell-off.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Envoy Medical shares fell by 7.91% to $1.63, with a market cap of $31.8 million.
The decrease in COCH's stock price could be indicative of a bearish short-term trend if investor concerns continue.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
GlucoTrack stock fell 15.5% to $0.19, with a market cap of $3.9 million.
The after-market decline for GCTK indicates negative investor sentiment, which may result in a continued decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Personalis shares fell 6.06% to $1.55, with a market cap of $76.0 million.
Personalis' after-market decline could signal a short-term downward trend if the selling pressure persists.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Sonnet BioTherapeutics stock fell 7.49% to $1.36, with a market cap of $2.3 million.
The drop in SONN's stock price may continue in the short term, reflecting a negative market reaction.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Verve Therapeutics shares decreased by 8.64% to $10.9, with a market cap of $694.9 million.
The after-market drop in VERV's stock price may lead to further short-term declines if the negative sentiment persists.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
180 Life Sciences shares rose 38.2% to $0.47, with a market cap of $3.4 million.
The significant after-market rise in ATNF's stock price suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Blue Water Biotech shares rose by 13.04% to $0.26, with a market cap of $4.8 million.
The positive movement in BWV's stock price could suggest a bullish short-term trend if investor interest remains high.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
CohBar shares climbed 12.96% to $0.86, with a market cap of $2.4 million.
CohBar's after-market rise could indicate a positive short-term trajectory, supported by investor confidence.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
DermTech stock moved upwards by 9.58% to $1.83, with a market cap of $62.6 million.
DermTech's stock price increase may continue in the short term, reflecting positive market reception.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Redhill Biopharma shares increased by 23.34% to $2.8, with a market cap of $30.9 million.
The substantial rise in RDHL's stock price could attract more attention and potentially lead to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Trinity Biotech stock increased by 15.25% to $0.52, with a market cap of $19.8 million.
The after-market increase in TRIB's stock price may lead to a positive short-term outlook if the momentum continues.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100